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Cystic hygromas, also known as lymphangiomas, are
unusual congenital malformations of the lymphatic system
and commonly involve the head and neck region or axilla.
Involvement of other sites such as breasts is very rare. The
preferred mode of treatment for lymphangioma of the
breast in adults or children is surgery. We report a case of
breast lymphangioma in a 3-month-old male child, which
was managed successfully by intralesional bleomycin.
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Introduction
Cystic lymphangioma (CL) is a multiloculated congenital
malformation of the lymphatic system, occurring in
approximately one in 6000–12 000 births. Almost all cases
are diagnosed by the age of 2 years [1]. This term comes
from the Greek word ‘hygroth’ meaning fluid and ‘oma’
meaning tumor. Cystic hygromas are slow-growing benign
tumors, resulting from a developmental anomaly of the
lymphatic system. It can affect any site of the body, but is
seen more commonly in the head and neck region and the
axilla. It is also reported to occur in the mediastinum,
retroperitoneum, breasts, and other regions [2]. Treat-
ment of CL occurring at unusual sites by large is
complete surgical excision if possible. We report a case
of an infant with breast CL, which was managed
successfully by intralesional bleomycin.
Case report
A 3-month-old male child weighting 5 kg presented with a
lump in the breast (Fig. 1). The lump progressively increased
in size and was not painful with no associated nipple
discharge. No history of trauma or previous surgery was
reported. On palpation, the lump was mobile and nontender
and involved almost the entire left breast with no significant
axillary lymphadenopathy. His general physical and systemic
examinations were unremarkable. Laboratory examinations
including complete blood count, serum electrolytes, liver
function tests, alkaline phosphatase levels, and thyroid
function tests were all within normal limits. Ultrasonography
of the breast showed a single large cystic lesion, located in the
lateral half of the breast, suggestive of lymphangioma (Fig. 2).
Aspiration under ultrasound guidance showed chylous fluid.
Considering the cystic nature and the presence of chylous
fluid on aspiration, the diagnosis of CL was made. As per our
treatment protocol, the patient was advised for intralesional
sclerotherapy. At our center, we use aqueous Bleomycin
solution as a sclerosing agent, because it is cheap, easily
available, effective, and safe. All interventions are performed
under general anesthesia/sedation. The cyst was punctured
under USG guidance, the content of the cyst was aspirated
completely, bleomycin was injected into the cyst, and care was
taken that the total dose should not exceed the recom-
mended dose [0.5 mg/kg (3 mg/ml solution)]. After the
procedure, compression of the injection site was performed
for 6 h. Strict monitoring of vitals was carried out up to 6 h
after the procedure, and the patient was discharged after 24 h.
At our center, we review every case after 3 months, and the
second session of review is carried out only after 6 months if
required. The patient was reviewed after 3 months: clinically
no palpable lump was detected (Fig. 3), and ultrasound
examination showed a small cystic lesion that was not
amenable for a second session. The patient is doing well at
the follow-up after 2 years.
Discussion
CL is a congenital malformation that likely results from
sequestration of lymphatic tissue that fails to communicate
with the rest of the lymphatic system. The origin of
lymphangiomas is not clearly understood. Most authors favor
the theory that dysplastic lymphatic tissue is sequestered in
a target tissue during fetal development [3], whereas
abdominal trauma, inflammatory processes, surgery, or
radiation therapy may lead to recurrence of such tumors [4].
They can occur anywhere in the body, but 75% involve the
posterior neck, 20% the axilla, and 1% the mediastinum,
groin, retroperitoneum, and breasts [5]. The breast is a very
infrequent site for the occurrence of the cystic subtype of
lymphangiomas, with very few cases documented in the
literature and is extremely rare in neonates [5].
Breast lymphangiomas tend to occur in the upper outer
quadrant of the breast [6], whereas in our case it involved
the whole breast. This pattern of location may be related
to the drainage pattern of the lymphatics in the breast,
which is mainly toward the tail and the axillary
region [6,7]. CL is mainly a childhood entity under
extremely rare instances when the breast is the primary
location; most of such cases have been reported in
adults [7,8]. Regarding the age distribution of CL, it has
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been reported usually in young females ranging from 4
months to 49 years of age [9]. Until now, only five [5,9–12]
cases (Table 1) of CL of the breast have been reported in
the world literature, of which only one was an infant.
A typical lesion of CL may consist of a single or an
aggregation of cysts; usually the larger cysts are located in
the periphery, whereas the smaller ones lie deeper and
may infiltrate in the neighboring structures [6]. On
histology, they are characterized by a single layer of
endothelium containing, usually, a clear watery fluid
(lymph). CLs are benign with no malignant potential,
painless, soft, and fluctuant malformations that may or
may not increase on coughing or crying and is brilliantly
translucent if the content is clear fluid [6]. Cystic
hygromas are benign lesions, but warrant urgent attention
because of the complications leading to sudden increase
in size. Rapid enlargement may occur, usually because of
hemorrhage into the cyst, inflammation, or trauma.
The differential diagnoses of CL of the breast include
simple cyst, abscess, hematoma, postoperative fluid
collection, and hemangioma. Simple cysts trends to occur
in both breasts and can often occur in other regions of the
same breast and the contents are turbid yellow or green.
Hemangiomas generally show thick-walled blood vessels
with numerous red blood cells that can be differentiated
by Doppler ultrasound [3].
In the head and neck region, clinical signs and symptoms
can confirm the diagnosis of CL. However, in atypical
places such as breasts, confirmation requires imaging
modalities such as Doppler ultrasound/MRI. Ultrasound
can usually confirm and differentiate cystic lymphatic
malformation with other cystic lesions. On ultrasonogra-
phy, CLs are seen as cystic multiloculated masses, with
linear septa of variable thickness that may contain solid
components, although in certain circumstances.
Our review of the literature revealed that CL of the breast
is mostly surgically excised. As these lesions are locally
aggressive and tend to infiltrate the surrounding tissues,
achieving safe surgical margins may at times be difficult.
To achieve complete clearance, wide local excision
including sacrifice of normal breast tissue can lead to
poor, long-term aesthetic and functional outcomes.
Keeping all these points in mind and our experience of
bleomycin sclerotherapy in the head and neck region,
intralesional bleomycin sclerotherapy was attempted after
Fig. 1
Cystic lesion in the left breast.
Fig. 2
Ultrasound showing the cystic lesion.
Fig. 3
Patient after 2 years of follow-up.
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informed consent in our patient with equivocal results
without scar.
We believe that intralesional bleomycin sclerotherapy can
be safely used for CL of the breast without long-term
complications.
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Table 1 Children with cystic lymphangioma of breast and their management
References Age (male) Sites Management Follow-up
Kangesu [9] 6 year Left breast (no details available) No details available No details available
Chiba et al. [5] 4 months Left breast (no details) Surgical excision 12 months
Singh et al. [12] 6 year Left breast (upper outer quadrant) Surgical excision 18 months
Gupta et al. [11] 8 year Right breast (upper outer quadrant) Surgical excision 9 months
Ekmez et al. [10] 5 year Left breast (upper half of breast) Surgical excision 12 months
This study 3 months Left breast (whole breast) Intralesional sclerotherapy 24 months
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